2Farkas A, Conrad C, Tonel G, et al. Current state and perspectives of dendritic cell vaccination in cancer immunotherapy [ J ]. Skin Pharmacol Physiol,2006,19 (3) : 124 - 131.
3Yasuda T, Kamigaki T, Nakamura T, et al. Dendritic cell-tumor cell hybrids enhance the induction of cytotoxic T lymphocytes against murine colon cancer: a comparative analysis of antigen loading methods for the vaccination of immunotherapeutic dendritic cells [J]. Oncol Rep, 2006,16(6) :1317 - 1324.
4Sievers E, Albers P, Schmidt Wolf IG, et al. Telomerase pulsed dendritic cells for immunotherapy for renal cell carcinoma [ J ]. Urology,2004,171 ( 1 ) :114 - 119.
5Hamada I, Kato M, Okada K,et al. Muhi-cytokine therapy for advanced renal cell carcinoma: determination of the minimal effective dose [ J ]. Anticancer Res, 2002,22 (4) : 2429 - 2436.
6Hemberg M, Muhonen T, Pyrhonen S. Can the CD4 ^+/CD8^+ ratio predict the outcome of interferon-α therapy for renal cell carcinoma [J] ? Ann Oncol, 1997,8:71 -77.
7Linn YC, Hui KM. Cytokine-induced killer cells: NK-like T cells with cytolytic specificity against leukemia [ J ]. Leuk Lymphoma, 2003,44(9) :1457 - 1462.
8Linn YC, Lau LC, Hui KM, et al. Generation of cytokine-induced killer cells from leukaemic samples with in vitro cytotoxicity against autologous and allogeneic leukaemic blasts [ J ]. Br J Haematol, 2002,116 ( 1 ) :78 - 86.
9[1]J efford M,Maraskovsky E,Cebon J,et al.The use of dendritic cells in cancer therapy.Lancet Oncol,2001,2(6):3432353.
10[2]Lan R,Wang F,J effery G,et al.Phase Ⅰ trial of int ravenous poptide-pulsed dendritic cells in patients with metastatic melanoma.J Immunother,2001,24 (1):66278.
